CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...
Phase 1, Phase 2
San Antonio, Texas, United States of America and 4 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
San Antonio, Texas, United States and 35 other locations
participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...
Phase 1, Phase 2
San Antonio, Texas, United States and 22 other locations
growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals of this study are to:* Learn how well...
Phase 2
San Antonio, Texas, United States and 6 other locations
positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...
Phase 1
San Antonio, Texas, United States and 10 other locations
to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...
Phase 1, Phase 2
San Antonio, Texas, United States of America and 55 other locations
The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...
Phase 3
San Antonio, Texas, United States and 126 other locations
The purpose of this study is to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combinati ...
Phase 1, Phase 2
San Antonio, Texas, United States of America and 3 other locations
The purpose of this study is to test BTX-9341 alone or in combination with fulvestrant (a currently marketed medication for breast cancer...
Phase 1
San Antonio, Texas, United States and 2 other locations
This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. It will find out w ...
Phase 1, Phase 2
San Antonio, Texas, United States and 49 other locations
Clinical trials
Research sites
Resources
Legal